A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status
Alessia Garufi(University of Chieti-Pescara), Gabriella D’Orazi(University of Chieti-Pescara)
Cited by 32
Related Papers
Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
|PLoS ONE|2009|49
Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapy
|Cell Death and Disease|2013|43
Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
|PLoS ONE|2012|29
Zn(II)-curc targets p53 in thyroid cancer cells
|International Journal of Oncology|2015|27